Valuation: Artivion, Inc.

Market Cap 1.1B 984M 901M 821M 1.54B 104B 1.57B 10.75B 4.34B 55.03B 4.13B 4.04B 174B P/E 2026 *
-64.5x
P/E 2027 * 82.9x
Enterprise Value 1.1B 984M 901M 821M 1.54B 104B 1.57B 10.75B 4.34B 55.03B 4.13B 4.04B 174B EV / Sales 2026 *
2.24x
EV / Sales 2027 * 2.03x
Free-Float
89.42%
Yield 2026 *
-
Yield 2027 * -
1 day+4.43%
1 week+1.20%
Current month+4.43%
1 month+7.52%
3 months-12.11%
6 months-34.88%
Current year-48.30%
1 week 21.85
Extreme 21.85
23.92
1 month 20.21
Extreme 20.21
24.24
Current year 19.16
Extreme 19.16
46.84
1 year 19.16
Extreme 19.16
48.25
3 years 13.18
Extreme 13.18
48.25
5 years 9.64
Extreme 9.64
48.25
10 years 9.64
Extreme 9.64
48.25
Manager TitleAgeSince
Chief Executive Officer 59 2014-09-01
Director of Finance/CFO 53 2023-12-03
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 71 2003-11-30
Director/Board Member 66 2003-11-30
Director/Board Member 61 2012-04-30
Date Insider Type Main position Quantity % Market Cap. Importance
9/10/26 Sell

General Counsel

-11,480 0.0235%
9/3/26 Sell

General Counsel

-1,493 0.0031%
8/19/26 Sell

Chief Executive Officer

-70,000 0.1442%
Change 5-day change 1-year change 3-year change Capi.($)
+4.43%+1.20%-48.03%+83.07% 1.1B
+3.73%+6.23%-10.89%+15.95% 184B
+2.85%+4.07%+9.47%+40.14% 118B
+5.12%-0.11%-13.88%+12.78% 111B
+1.41%+3.15%-41.10%+9.03% 94.58B
+2.12%+2.07%+0.01%+80.44% 63.13B
-5.48%-5.08%-1.24%+63.86% 55.66B
+0.36%-0.16%+11.13%-21.74% 53.9B
+21.85%+19.85%+6.69%+69.88% 43.42B
+2.23%+4.28%+1.04%-7.87% 34.68B
Average +3.57%-0.26%-8.68%+34.55% 75.95B
Weighted average by Cap. +2.98%+0.23%-7.25%+26.68%

Financials

2026 *2027 *
Net sales 491M 439M 402M 366M 686M 46.56B 701M 4.79B 1.93B 24.52B 1.84B 1.8B 77.5B 544M 486M 445M 406M 760M 51.58B 777M 5.31B 2.14B 27.17B 2.04B 2B 85.86B
Net income -15.84M -14.16M -12.97M -11.82M -22.16M -1.5B -22.65M -155M -62.46M -792M -59.44M -58.19M -2.5B 12.11M 10.83M 9.92M 9.03M 16.94M 1.15B 17.31M 118M 47.75M 605M 45.43M 44.48M 1.91B
Net Debt - -
Projected Income Statement - Annual - Artivion, Inc.
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
1,800
Date Price Change Volume
26-11-02 $23.58 +4.43% 626,155
26-10-30 $22.58 -3.67% 627,384
26-10-29 $23.44 +2.27% 418,196
26-10-28 $22.92 -0.09% 421,650
26-10-27 $22.94 -0.17% 405,207
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - Artivion, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
23.58USD
Average target price
40.91USD
Spread / Average Target
+73.50%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Artivion, Inc.
  1. Stock Market
  2. Stocks
  3. AORT Stock